These recurrent IDH‐mutant gliomas with secondary MMR deficiency comprise the first of the two described entities of diffuse gliomas with co‐occurrence of IDH mutation, MMR deficiency, and hypermutation. Here, IDH2 is linked to mismatch repair cancer syndrome 1.